414 related articles for article (PubMed ID: 18019783)
1. [Fixed-dose combinations in the first line of antihypertensive therapy].
Urbán L; Mészáros A
Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
[TBL] [Abstract][Full Text] [Related]
2. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy.
Epstein M; Bakris G
Arch Intern Med; 1996 Sep; 156(17):1969-78. PubMed ID: 8823150
[TBL] [Abstract][Full Text] [Related]
3. Rationale for the use of very-low-dose combinations as first-line treatment of hypertension.
Waeber B; Brunner HR
J Hypertens Suppl; 2001 Nov; 19(4):S3-8. PubMed ID: 11848261
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy as first-line treatment of arterial hypertension.
Ruzicka M; Leenen FH
Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
[TBL] [Abstract][Full Text] [Related]
5. Combination versus Monotherapy as Initial Treatment in Hypertension.
Holzgreve H
Herz; 2003 Dec; 28(8):725-32. PubMed ID: 14689107
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
7. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
Chatzikyrkou C; Haller H; Menne J
Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
[TBL] [Abstract][Full Text] [Related]
8. Healthcare benefits of very-low-dose combination treatment used in the management of hypertension.
Ambrosioni E
J Hypertens Suppl; 2001 Nov; 19(4):S29-36. PubMed ID: 11848260
[TBL] [Abstract][Full Text] [Related]
9. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
[TBL] [Abstract][Full Text] [Related]
10. Low-dose combinations versus monotherapies in the treatment of hypertension.
Waeber B; Brunner HR
J Hypertens Suppl; 1997 Mar; 15(2):S17-20. PubMed ID: 9218193
[TBL] [Abstract][Full Text] [Related]
11. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
Neutel JM
Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
[TBL] [Abstract][Full Text] [Related]
12. Hypertension: the rediscovery of combination therapy.
Prisant LM; Doll NC
Geriatrics; 1997 Nov; 52(11):28-30, 33-8. PubMed ID: 9371101
[TBL] [Abstract][Full Text] [Related]
13. [The rationale for drug combinations in the therapy of arterial hypertension].
Salvetti A; Virdis A; Di Venanzio L
Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
[TBL] [Abstract][Full Text] [Related]
14. Fixed-dose combinations improve medication compliance: a meta-analysis.
Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
[TBL] [Abstract][Full Text] [Related]
15. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
16. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
17. A role for single-pill triple therapy in hypertension.
Elijovich F; Laffer C
Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
[TBL] [Abstract][Full Text] [Related]
18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
19. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
20. Use of single-pill combination therapy in the evolving paradigm of hypertension management.
Calhoun DA
Expert Opin Pharmacother; 2009 Aug; 10(12):1869-74. PubMed ID: 19496740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
